This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
PROfound
VISION Trial
mHSPC
ARASENS Trial
nmCRPC
ARAMIS Trial
nmCSPC
EMBARK Trial
PSMA PET Imaging
COBRA
CONDOR Trial
OSPREY Trial
Bladder Cancer
Bladder Cancer Detection
CORE-001
CS-003
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Ruchika Talwar, MD
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Shilpa Gupta, MD
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Endourology
Endourology
Jaime Landman, MD
Prostate Cancer
Decipher Genomic Classifier
Advanced Prostate Cancer
Zachary Klaassen, MD, MSc
CRPC with Bone Metastases
Rana R. McKay, MD
Imaging Center
Phillip Koo, MD
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
mHSPC
Neeraj Agarwal, FASCO, MD
nmCRPC
Zachary Klaassen, MD, MSc
PSMA-Targeted Therapy
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular Cancer
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Pelvic Health
Diane K. Newman, DNP, ANP-BC, FAAN
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
Stephen R. Kraus, MD
Urologic Catheters (Includes CAUTI)
Diane K. Newman, DNP, ANP-BC, FAAN
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Medical Education
Covid-19
The Prostate Cancer Foundation
Health Policy in Urological Diseases
Disparities: Social Determinants of Health
Practice Guidelines Reviews
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Pelvic Health & Reconstruction
Pelvic Health & Reconstruction
Trials in Progress
Trials in Progress
Bladder Cancer
IMMORTAL
PIVOT-006
Kidney Cancer
RadiCal
SAMURAI
Middle Side
Prostate Cancer
ARAMON
ARASEC
ARASTEP
CLARIFY
ECLIPSE
ESCAPE
FORT
Right Side
Prostate Cancer
Masofaniten (EPI-7386)
METANOVA
NRG-GU 0101
PROMISE
RTIRE
SECuRE
SHORTER
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
WCET 2024
BCAN TT 2024
SNMMI 2024
ASCO 2024
AUA 2024
All Conferences
View All
PCF
UroToday Home
Recent Abstracts
Urologic Oncology
Prostate Cancer
Recent Abstracts
Physiopathology and new therapeutic strategies in the management of bone metastases of prostate cancer - Abstract
May 13, 2011
Outcome after conformal salvage radiotherapy in patients with rising prostate-specific antigen levels after radical prostatectomy - Abstract
May 13, 2011
Human collagen injections to reduce rectal dose during radiotherapy - Abstract
May 13, 2011
Critical assessment of the European Association of Urology guideline indications for pelvic lymph node dissection at radical prostatectomy - Abstract
May 12, 2011
Difference in willingness-to-pay for prostate cancer screening between ill-informed and well-informed men: A contingent valuation survey - Abstract
May 12, 2011
Time to castration resistance is an independent predictor of castration-resistant prostate cancer survival - Abstract
May 12, 2011
Investigative clinical study on prostate cancer part IV: Exploring functional relationships of total testosterone predicting free testosterone and total prostate-specific antigen in operated prostate cancer patients - Abstract
May 12, 2011
Whole-body MRI including diffusion-weighted imaging (DWI) for patients with recurring prostate cancer: Technical feasibility and assessment of lesion conspicuity in DWI - Abstract
May 12, 2011
MRI-guided prostate biopsy detects clinically significant cancer: Analysis of a cohort of 100 patients after previous negative TRUS biopsy - Abstract
May 12, 2011
Clinical efficacy of primary combined androgen blockade for Japanese men with clinically localized prostate cancer unsuitable for local definitive treatment: A single institution experience - Abstract
May 12, 2011
Updating the prostate cancer risk indicator for contemporary biopsy schemes - Abstract
May 12, 2011
Prostate adenocarcinoma with orbital metastasis in an HIV+ man - Abstract
May 12, 2011
Clinical and histopathological characteristics of familial prostate cancer in Finland - Abstract
May 12, 2011
New findings in bladder and prostate cancer: Highlights from the 26th annual congress of the European Association of Urology, March 18-22, 2011, Vienna, Austria - Abstract
May 11, 2011
Perioperative, functional and oncological outcomes after open and minimally invasive prostate cancer surgery: Experience from Australasia - Abstract
May 11, 2011
Do Maori and Pacific Islander men present with more advanced prostate cancer than European New Zealand men? An analysis of 486 men undergoing biopsy in Auckland - Abstract
May 11, 2011
Dramatic increase in prostate cancer cases by 2021 - Abstract
May 11, 2011
Validation of postoperative nomograms in prostate cancer patients with long-term follow-up - Abstract
May 11, 2011
PCA3 urinary test versus 1H-MRSI and DCEMR in the detection of prostate cancer foci in patients with biochemical alterations - Abstract
May 11, 2011
The value and limitations of contrast-enhanced ultrasound in detection of prostate cancer - Abstract
May 11, 2011
Page 1383 of 1418
Start
Prev
1378
1379
1380
1381
1382
1383
1384
1385
1386
1387
Next
End
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free